SKAN Group AGFRA:7VG +2.61%62 EBIT per Share is €1.07 as of Dec. 2025. GuruFocus rates FRA:7VG with a GF Score™ of 62/100 and a GF Value™ of €90.91 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 687 Medical Devices & Instruments companies, SKAN Group AG ranks worse than 69.43% on this metric.
SKAN Group AG's EBIT per Share for the
six
months ended in Dec. 2025 was €1.24.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €1.07.
During the past 12 months, the average EBIT per Share Growth Rate of SKAN Group AG was -42.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -4.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 14.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for SKAN Group AG's EBIT per Share or its related term are showing as below:
FRA:7VG'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -4.8 Med: 2.8 Max: 52.2
Current: -4.8
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of SKAN Group AG was 52.20% per year. The lowest was -4.80% per year. And the median was 2.80% per year.
FRA:7VG's 3-Year EBIT Growth Rate is ranked worse than 69.43% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs FRA:7VG: -4.80
SKAN Group AG's EBIT for the
six
months ended in Dec. 2025 was €28.0 Mil.
SKAN Group AG (FRA:7VG) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
SKAN Group AG EBIT per Share Related Terms
SKAN Group AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKAN Group AG (FRA:7VG) has a EBIT per Share of €1.07 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on SKAN Group AG and its competitors. According to the industry distribution chart, SKAN Group AG ranks #477 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 69.4%.
Is SKAN Group AG's EBIT per Share too high?
SKAN Group AG's current EBIT per Share is €1.07. Based on the distribution chart, SKAN Group AG ranks #477 out of 687 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SKAN Group AG has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #477 out of 687 companies for EBIT per Share. This places SKAN Group AG in the lower half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current EBIT per Share is €1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €90.91, compared to a current price of €59.00 — trading 35.1% below its estimated fair value. The current EBIT per Share is €1.07. SKAN Group AG's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current EBIT per Share is €1.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (FRA:7VG) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of €59.00 is trading 35.1% below its estimated GF Value™ of €90.91.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for FRA:7VG:
EBIT per Share: €1.07
GF Value™: €90.91 vs. price of €59.00 (35.1% below fair value)
No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
62GF Score
Get the complete analysis for FRA:7VG
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7VG has been successfully added to your 
